Literature DB >> 24350865

Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.

Sarita S Hardas1, Rukhsana Sultana, Govind Warrier, Mo Dan, Peng Wu, Eric A Grulke, Michael T Tseng, Jason M Unrine, Uschi M Graham, Robert A Yokel, D Allan Butterfield.   

Abstract

Ceria engineered nanomaterials (ENMs) have very promising commercial and therapeutic applications. Few reports address the effects of nanoceria in intact mammals, let alone long term exposure. This knowledge is essential to understand potential therapeutic applications of nanoceria in relation to its hazard assessment. The current study elucidates oxidative stress responses in the rat hippocampus 1 and 20 h, and 1, 7, 30 and 90 days following a single systemic infusion of 30 nm nanoceria. The results are incorporated into a previously described hierarchical oxidative stress (HOS) model. During the 1-20 h period, increases of the GSSG: GSH ratio and cytoprotective phase-II antioxidants were observed. During the 1-7 d period, cytoprotective phase-II antioxidants activities were inhibited with concomitant elevation of protein carbonyl (PC), 3-nitrotyrosine (3NT), heme oxygenase-1 (HO-1), cytokine IL-1β and the autophagy marker LC-3AB. At 30 day post ceria infusion, oxidative stress had its major impact. Phase-II enzyme activities were inhibited; concurrently PC, 3NT, HO-1 and Hsp70 levels were elevated along with augmentation of IL-1β, pro-apoptotic pro-caspase-3 and LC-3AB levels. This progress of escalating oxidative stress was reversed at 90 days when phase-II enzyme levels and activities were restored to normal levels, PC and 3NT levels were reduced to baseline, cytokine and pro-caspase-3 levels were suppressed, and cellular redox balance was restored in the rat hippocampus. This study demonstrates that a single administration of nanoceria induced oxidative stress that escalates to 30 days then terminates, in spite of the previously reported continued presence of nanoceria in peripheral organs. These results for the first time confirm in vivo the HOS model of response to ENM previously posited based on in vitro studies and extends this prior hierarchical oxidative stress model that described three tiers to a 4th tier, characterized by resolution of the oxidative stress and return to normal conditions.

Entities:  

Keywords:  Engineered nanomaterial; hierarchical model; hippocampus; nanoceria; oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 24350865     DOI: 10.3109/17435390.2013.868059

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  11 in total

1.  Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.

Authors:  Erez Eitan; Emmette R Hutchison; Nigel H Greig; David Tweedie; Hasan Celik; Soumita Ghosh; Kenneth W Fishbein; Richard G Spencer; Carl Y Sasaki; Paritosh Ghosh; Soumen Das; Susheela Chigurapati; James Raymick; Sumit Sarkar; Srinivasulu Chigurupati; Sudipta Seal; Mark P Mattson
Journal:  Exp Neurol       Date:  2015-08-13       Impact factor: 5.330

2.  Analytical High-resolution Electron Microscopy Reveals Organ-specific Nanoceria Bioprocessing.

Authors:  Uschi M Graham; Robert A Yokel; Alan K Dozier; Lawrence Drummy; Krishnamurthy Mahalingam; Michael T Tseng; Eileen Birch; Joseph Fernback
Journal:  Toxicol Pathol       Date:  2017-11-16       Impact factor: 1.902

Review 3.  From Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity.

Authors:  Uschi M Graham; Gary Jacobs; Robert A Yokel; Burtron H Davis; Alan K Dozier; M Eileen Birch; Michael T Tseng; Günter Oberdörster; Alison Elder; Lisa DeLouise
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety.

Authors:  Beverly A Rzigalinski; Charles S Carfagna; Marion Ehrich
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-11-08

5.  Yttrium chloride-induced cytotoxicity and DNA damage response via ROS generation and inhibition of Nrf2/PPARγ pathways in H9c2 cardiomyocytes.

Authors:  Liang Xiong; Jinyu Huang; Sihui Wang; Qiong Yuan; Dongmei Yang; Zuobing Zheng; Yangna Wu; Chunmei Wu; Yanfang Gao; Lijun Zou; Gonghua Hu
Journal:  Arch Toxicol       Date:  2022-01-27       Impact factor: 5.153

6.  In Vivo Processing of Ceria Nanoparticles inside Liver: Impact on Free-Radical Scavenging Activity and Oxidative Stress.

Authors:  Uschi M Graham; Michael T Tseng; Jacek B Jasinski; Robert A Yokel; Jason M Unrine; Burtron H Davis; Alan K Dozier; Sarita S Hardas; Rukhsana Sultana; Eric A Grulke; D Allan Butterfield
Journal:  Chempluschem       Date:  2014-08       Impact factor: 2.863

7.  The Yin: An adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicity.

Authors:  Robert A Yokel; Salik Hussain; Stavros Garantziotis; Philip Demokritou; Vincent Castranova; Flemming R Cassee
Journal:  Environ Sci Nano       Date:  2014-10-01

Review 8.  Central nervous system toxicity of metallic nanoparticles.

Authors:  Xiaoli Feng; Aijie Chen; Yanli Zhang; Jianfeng Wang; Longquan Shao; Limin Wei
Journal:  Int J Nanomedicine       Date:  2015-07-03

9.  Cerium oxide nanoparticles inhibit differentiation of neural stem cells.

Authors:  Anda R Gliga; Karin Edoff; Fanny Caputo; Thomas Källman; Hans Blom; Hanna L Karlsson; Lina Ghibelli; Enrico Traversa; Sandra Ceccatelli; Bengt Fadeel
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

10.  Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA.

Authors:  Ana Y Estevez; Mallikarjunarao Ganesana; John F Trentini; James E Olson; Guangze Li; Yvonne O Boateng; Jennifer M Lipps; Sarah E R Yablonski; William T Donnelly; James C Leiter; Joseph S Erlichman
Journal:  Biomolecules       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.